Jim Nelson

Intellectual Property

About Jim Nelson

Schwegman, Lundberg & Woessner

121 S 8th St #1600 Minneapolis, Minnesota 55402

jnelson@slwip.com

(612) 373-6939

View Lawyer's Website

Topics Addressed by This Lawyer

BioSimilars

Demonstrating BioSimilarity Under U.S. Law

Litigation and BioSimilar Patenting

Approvals of BioSimilars in Europe

FDA Guidelines for Demonstrating Biosimilarity

Merrifield Synthesis

Who Determines Substitution Factors?

Impact of US Hatch Waxman Act 1984

Why Are Biologicals so Important?

How to Navigate BioSimilar Challenges

Naming Problems with BioSimilars

Biologics Price Competition and Innovation Act

Claim Maps and BioSimilars

What is a BioSimilar?

Are BioSimilars Being Approved in the US?

What is a BioSimilar Product Under US Law?

BioSimilar Patenting Litigation Involving Large Amounts of Money

Sponsor

Biologics vs Small Molecules

Top Rated Intellectual Property Law

Experience

Technical Background

Rewards of the Practice

Top Rated Intellectual Property Law Firm

Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals